<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00001595</url>
  </required_header>
  <id_info>
    <org_study_id>970076</org_study_id>
    <secondary_id>97-CH-0076</secondary_id>
    <nct_id>NCT00001595</nct_id>
  </id_info>
  <brief_title>An Investigation of Pituitary Tumors and Related Hypothalmic Disorders</brief_title>
  <official_title>A Clinical and Genetic Investigation of Pituitary and HYPOTHALAMIC Tumors and Related Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is a variety of tumors affecting the pituitary gland in childhood; some of these tumors
      (eg craniopharyngioma) are included among the most common central nervous system tumors in
      childhood. The gene(s) involved in the pathogenesis of these tumors are largely not known;
      their possible association with other developmental defects or inheritance pattern(s) has not
      been investigated. The present study serves as a (i) screening/training, and, (ii) a research
      protocol.

      As a screening and training study, this protocol allows our Institute to admit children with
      tumors of the hypothalamic-pituitary unit to the pediatric endocrine clinics and wards of the
      NIH Clinical Center for the purposes of

      (i)&lt;TAB&gt;training our fellows and students in the identification of genetic defects associated
      with pituitary tumor formation, and

      (ii)&lt;TAB&gt;teaching our fellows and students the recognition, management and complications of
      pituitary tumors

      As a research study, this protocol aims at

      (i)&lt;TAB&gt;developing new clinical studies for the recognition and therapy of pituitary tumors;
      as an example, two new studies have emerged within the context of this protocol: (a)
      investigation of a new research magnetic resonance imaging (MRI) tool and its usefulness in
      the identification of pituitary tumors, and (b) investigation of the psychological effects of
      cortisol secretion in pediatric patients with Cushing disease. Continuation of this protocol
      will eventually lead to new, separate protocols that will address all aspects of diagnosis of
      pituitary tumors and their therapy in childhood.

      (ii)&lt;TAB&gt;Identifying the genetic components of pituitary oncogenesis; those will be
      investigated by (a) studying the inheritance pattern of pituitary tumors in childhood and
      their possible association with other conditions in the families of the patients, and (ii)
      collecting tumor tissues and examining their molecular genetics. As with the clinical
      studies, the present protocol may help generate ideas for future studies on the treatment and
      clinical follow up of pediatric patients with tumors of the pituitary gland and, thus, lead
      to the development of better therapeutic regimens for these neoplasms.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      There are a variety of tumors affecting the pituitary gland and hypothalamus; the gene(s)
      involved in the pathogenesis of these tumors are largely not known; their possible
      association with other developmental defects or inheritance pattern(s) has not been
      investigated. The present study serves as a (i) screening, and, (ii) an observational
      research protocol.

      As a screening study, this protocol allows our Institute to admit patients with tumors of the
      hypothalamic-pituitary unit to the clinics and wards of the NIH Clinical Center for the
      purposes of determining eligibility for CC protocols.

      As an observational research study, this protocol aims at:

      Developing new clinical studies for the recognition and therapy of pituitary tumors; as an
      example, a new study had emerged within the context of this protocol: investigation of the
      psychological effects of cortisol secretion in pediatric (only) patients with Cushing
      disease, and (c) to study (longitudinally) whether CS in pediatric patients is also
      associated with a hypercoagulable state. Continuation of this protocol will eventually lead
      to new, separate protocols that will address all aspects of diagnosis of pituitary tumors and
      their therapy in childhood.

      Identifying the genetic components of pituitary oncogenesis; those will be investigated by
      (a) studying the inheritance pattern of pituitary tumors in childhood and their possible
      association with other conditions in the families of the patients, collecting tumor tissues
      and examining their molecular genetics, and using whole exome/genome sequencing (WE/GS) and
      related techniques in identifying genetic predisposition or causative factors.

      As with clinical studies, the present protocol may help generate ideas for future studies on
      the treatment and clinical follow up of patients with tumors of the pituitary gland and,
      thus, lead to the development of better therapeutic regimens for these neoplasms
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 21, 1997</start_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>a tissue and blood DNA collection</measure>
    <time_frame>ongoing</time_frame>
    <description>Genetic studies of pituitary and hypothalamic tumors or related disorders</description>
  </primary_outcome>
  <primary_outcome>
    <measure>training vehicle for our Endocrinology fellows.</measure>
    <time_frame>ongoing</time_frame>
    <description>ACGME testing</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate the cognitive,psychological, and patient-reported health status of mental and social well-being and symptoms of adrenal insufficiency associated with Cushing syndrome in children with this disease.</measure>
    <time_frame>ongoing</time_frame>
    <description>Descriptive study of cognitive, psychological, and patientreported health status of mental and social well-being associated with Cushing and after treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To investigate the usefulness of a new MRI of the pituitary gland</measure>
    <time_frame>completed</time_frame>
    <description>Comparison of MRI techniques to identify micro adenomas</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>to collect peripheral blood DNA samples and tumor tissues and examine the molecular genetics of the specimens, in an effort to elucidate developmental pathways leading to pituitary gland oncogenesis and/or other defects</measure>
    <time_frame>ongoing</time_frame>
    <description>Genetic studies of pituitary and hypothalamic tumors or related disorders</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To identify the clinical and genetic features of pituitary tumors by investigating their inheritance pattern and possible association with other conditions in the families of the patients</measure>
    <time_frame>ongoing</time_frame>
    <description>Genetic studies of pituitary and hypothalamic tumors or related disorders</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Panhypopituitarism</condition>
  <condition>Gigantism/Acromegaly</condition>
  <condition>Prolactinoma</condition>
  <condition>Cushing Disease</condition>
  <arm_group>
    <arm_group_label>Patients with pituitary tumors or hypothalamic defects</arm_group_label>
    <description>Patients with pituitary tumors or hypothalamic defects</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with known or suspected pituitary or hypothalamic tumors or related disorders.
        Family members (adult and pediatric; affected and unaffected) may be enrolled in the DNA
        linkage analysis part of this protocol.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:

          -  Patients eligible for the study (3- 70 years old).

          -  Evidence for the existence of a tumor of the hypothalamic-pituitary unit, as indicated
             by previously obtained imaging studies or

        biochemical investigation of the hypothalamo-hypophyseal function.

          -  Family members (any age) of patients with a family history of tumors and who will
             agree to participate in the DNA/linkage analysis study.

          -  Member of a kindred suspected of having an inherited form of pituitary neoplasia, as
             evidenced by results of a patient studied under A (above).

        EXCLUSION CRITERIA:

        -Children younger than 3 years cannot be admitted and treated at the NIH Clinical Center
        due to lack of specialized infant and small

        children units; likewise, older patients may not be admitted due to lack of appropriate
        geriatric care.

        -Pregnant women are excluded from enrollment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Constantine A Stratakis, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Margaret F Keil, C.R.N.P.</last_name>
    <phone>(301) 435-3391</phone>
    <email>keilm@mail.nih.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Constantine A Stratakis, M.D.</last_name>
    <phone>(301) 402-8757</phone>
    <email>stratakc@mail.nih.gov</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center, 9000 Rockville Pike</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)</last_name>
      <phone>800-411-1222</phone>
      <phone_ext>TTY8664111010</phone_ext>
      <email>prpl@cc.nih.gov</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_1997-CH-0076.html</url>
    <description>NIH Clinical Center Detailed Web Page</description>
  </link>
  <reference>
    <citation>Trivellin G, Daly AF, Faucz FR, Yuan B, Rostomyan L, Larco DO, Schernthaner-Reiter MH, Szarek E, Leal LF, Caberg JH, Castermans E, Villa C, Dimopoulos A, Chittiboina P, Xekouki P, Shah N, Metzger D, Lysy PA, Ferrante E, Strebkova N, Mazerkina N, Zatelli MC, Lodish M, Horvath A, de Alexandre RB, Manning AD, Levy I, Keil MF, Sierra Mde L, Palmeira L, Coppieters W, Georges M, Naves LA, Jamar M, Bours V, Wu TJ, Choong CS, Bertherat J, Chanson P, Kamenick√Ω P, Farrell WE, Barlier A, Quezado M, Bjelobaba I, Stojilkovic SS, Wess J, Costanzi S, Liu P, Lupski JR, Beckers A, Stratakis CA. Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. N Engl J Med. 2014 Dec 18;371(25):2363-74. doi: 10.1056/NEJMoa1408028. Epub 2014 Dec 3.</citation>
    <PMID>25470569</PMID>
  </reference>
  <reference>
    <citation>Stratakis CA, Carney JA, Lin JP, Papanicolaou DA, Karl M, Kastner DL, Pras E, Chrousos GP. Carney complex, a familial multiple neoplasia and lentiginosis syndrome. Analysis of 11 kindreds and linkage to the short arm of chromosome 2. J Clin Invest. 1996 Feb 1;97(3):699-705.</citation>
    <PMID>8609225</PMID>
  </reference>
  <reference>
    <citation>Magiakou MA, Mastorakos G, Oldfield EH, Gomez MT, Doppman JL, Cutler GB Jr, Nieman LK, Chrousos GP. Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med. 1994 Sep 8;331(10):629-36.</citation>
    <PMID>8052272</PMID>
  </reference>
  <verification_date>July 8, 2020</verification_date>
  <study_first_submitted>November 3, 1999</study_first_submitted>
  <study_first_submitted_qc>November 3, 1999</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 1999</study_first_posted>
  <last_update_submitted>July 9, 2020</last_update_submitted>
  <last_update_submitted_qc>July 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Developmental Defect</keyword>
  <keyword>Oncogenesis</keyword>
  <keyword>Evaluation and Management</keyword>
  <keyword>Psychological</keyword>
  <keyword>Cushing Disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>ACTH-Secreting Pituitary Adenoma</mesh_term>
    <mesh_term>Prolactinoma</mesh_term>
    <mesh_term>Acromegaly</mesh_term>
    <mesh_term>Gigantism</mesh_term>
    <mesh_term>Pituitary ACTH Hypersecretion</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

